| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 7.63e-05 | 49 | 92 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.02e-04 | 20 | 92 | 3 | GO:0061665 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.70e-06 | 20 | 92 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 JAK1 SMG1 POGLUT3 NAA15 RGPD8 JMJD6 ENPP2 RGPD3 NSD1 AKT1 AKT2 BRSK1 PARD3 NOS1 IFNAR1 | 5.97e-06 | 976 | 92 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | double-strand break repair via alternative nonhomologous end joining | 7.07e-06 | 9 | 92 | 3 | GO:0097681 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 7.07e-06 | 9 | 92 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.01e-05 | 10 | 92 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | retinal cell apoptotic process | 1.01e-05 | 10 | 92 | 3 | GO:1990009 | |
| GeneOntologyBiologicalProcess | proacrosomal vesicle fusion | 1.97e-05 | 2 | 92 | 2 | GO:0120211 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.38e-05 | 13 | 92 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.02e-05 | 14 | 92 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 9.81e-05 | 103 | 92 | 5 | GO:0048814 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 1.17e-04 | 4 | 92 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 1.17e-04 | 4 | 92 | 2 | GO:0140213 | |
| GeneOntologyBiologicalProcess | apical constriction | 1.95e-04 | 5 | 92 | 2 | GO:0003383 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport to plasma membrane | 2.59e-04 | 28 | 92 | 3 | GO:0098877 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 3.13e-04 | 132 | 92 | 5 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RGPD4 RGPD8 ENPP2 RGPD3 NSD1 AKT1 EEF2K AKT2 ACVR2A RB1CC1 ADTRP PARD3 NOS1 CHRNA3 IFNAR1 | 3.27e-04 | 1226 | 92 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.36e-04 | 134 | 92 | 5 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import across plasma membrane | 4.07e-04 | 7 | 92 | 2 | GO:0010746 | |
| GeneOntologyBiologicalProcess | peripheral nervous system axon ensheathment | 4.25e-04 | 33 | 92 | 3 | GO:0032292 | |
| GeneOntologyBiologicalProcess | myelination in peripheral nervous system | 4.25e-04 | 33 | 92 | 3 | GO:0022011 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.70e-04 | 625 | 92 | 10 | GO:0051960 | |
| GeneOntologyBiologicalProcess | centrosome localization | 5.07e-04 | 35 | 92 | 3 | GO:0051642 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RGPD4 NSMF RGPD8 ENPP2 RGPD3 NSD1 AKT1 EEF2K AKT2 ACVR2A RB1CC1 ADTRP PARD3 NOS1 CHRNA3 IFNAR1 | 5.09e-04 | 1421 | 92 | 16 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RGPD4 NSMF RGPD8 ENPP2 RGPD3 NSD1 AKT1 EEF2K AKT2 ACVR2A RB1CC1 ADTRP PARD3 NOS1 CHRNA3 IFNAR1 | 5.17e-04 | 1423 | 92 | 16 | GO:0051174 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RGPD4 NSMF RGPD8 ENPP2 RGPD3 AKT1 AKT2 ACVR2A RB1CC1 ADTRP NOS1 CHRNA3 | 5.25e-04 | 879 | 92 | 12 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RGPD4 NSMF RGPD8 ENPP2 RGPD3 AKT1 AKT2 ACVR2A RB1CC1 ADTRP NOS1 CHRNA3 | 5.25e-04 | 879 | 92 | 12 | GO:0010562 |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 5.51e-04 | 36 | 92 | 3 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 5.63e-04 | 150 | 92 | 5 | GO:0050773 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 5.64e-04 | 319 | 92 | 7 | GO:0018209 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 5.97e-04 | 422 | 92 | 8 | GO:1990778 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 6.47e-04 | 38 | 92 | 3 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin maintenance | 6.94e-04 | 9 | 92 | 2 | GO:0032287 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 6.94e-04 | 9 | 92 | 2 | GO:0140212 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RGPD4 RGPD8 ENPP2 RGPD3 AKT1 AKT2 ACVR2A RB1CC1 ADTRP NOS1 CHRNA3 | 6.97e-04 | 780 | 92 | 11 | GO:0042327 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 4.55e-06 | 8 | 92 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.68e-06 | 10 | 92 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.90e-05 | 14 | 92 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | cell cortex | 3.77e-05 | 371 | 92 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 6.42e-05 | 18 | 92 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 8.91e-05 | 20 | 92 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | dendritic spine | 9.70e-05 | 242 | 92 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.04e-04 | 21 | 92 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | neuron spine | 1.10e-04 | 247 | 92 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | apical cortex | 8.43e-04 | 10 | 92 | 2 | GO:0045179 | |
| GeneOntologyCellularComponent | nuclear membrane | 8.85e-04 | 349 | 92 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear pore | 1.04e-03 | 101 | 92 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | transferase complex | RGPD4 GTF2F2 NAA15 RGPD8 ANAPC1 RGPD3 NSD1 CHD8 ACVR2A RB1CC1 PARD3 KLHL22 | 1.04e-03 | 963 | 92 | 12 | GO:1990234 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.25e-06 | 16 | 74 | 4 | MP:0003701 | |
| Domain | Grip | 1.85e-07 | 11 | 93 | 4 | SM00755 | |
| Domain | GRIP | 1.85e-07 | 11 | 93 | 4 | PF01465 | |
| Domain | Ran_BP1 | 2.77e-07 | 12 | 93 | 4 | PF00638 | |
| Domain | RANBD1 | 2.77e-07 | 12 | 93 | 4 | PS50196 | |
| Domain | GRIP_dom | 2.77e-07 | 12 | 93 | 4 | IPR000237 | |
| Domain | GRIP | 2.77e-07 | 12 | 93 | 4 | PS50913 | |
| Domain | RanBD | 3.98e-07 | 13 | 93 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 3.98e-07 | 13 | 93 | 4 | IPR000156 | |
| Domain | Rab_bind | 4.12e-06 | 7 | 93 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 4.12e-06 | 7 | 93 | 3 | IPR032023 | |
| Domain | PH_dom-like | RGPD4 JAK1 RGPD8 FRMD6 RGPD3 AKT1 AKT2 PLEKHH2 ARAP1 ARAP2 RGPD5 | 8.69e-06 | 426 | 93 | 11 | IPR011993 |
| Domain | - | 1.40e-05 | 10 | 93 | 3 | 1.10.220.60 | |
| Domain | DUF3534 | 2.45e-05 | 2 | 93 | 2 | IPR021922 | |
| Domain | DUF3534 | 2.45e-05 | 2 | 93 | 2 | PF12053 | |
| Domain | Kinase-like_dom | JAK1 SMG1 MYLK SMARCC1 CHD9 AKT1 EEF2K AKT2 ACVR2A BRSK1 STK31 | 7.88e-05 | 542 | 93 | 11 | IPR011009 |
| Domain | - | 1.44e-04 | 391 | 93 | 9 | 2.30.29.30 | |
| Domain | BRCT_dom | 3.58e-04 | 28 | 93 | 3 | IPR001357 | |
| Domain | BRK | 3.63e-04 | 6 | 93 | 2 | SM00592 | |
| Domain | BRK_domain | 3.63e-04 | 6 | 93 | 2 | IPR006576 | |
| Domain | BRK | 3.63e-04 | 6 | 93 | 2 | PF07533 | |
| Domain | Chromo/shadow_dom | 5.85e-04 | 33 | 93 | 3 | IPR000953 | |
| Domain | CHROMO | 5.85e-04 | 33 | 93 | 3 | SM00298 | |
| Domain | PDZ | 6.97e-04 | 141 | 93 | 5 | PF00595 | |
| Domain | RA | 7.58e-04 | 36 | 93 | 3 | PF00788 | |
| Domain | RA | 8.21e-04 | 37 | 93 | 3 | PS50200 | |
| Domain | PDZ | 8.67e-04 | 148 | 93 | 5 | SM00228 | |
| Domain | TPR-contain_dom | 9.21e-04 | 150 | 93 | 5 | IPR013026 | |
| Domain | - | 9.21e-04 | 150 | 93 | 5 | 2.30.42.10 | |
| Domain | PDZ | 9.49e-04 | 151 | 93 | 5 | PS50106 | |
| Domain | PDZ | 9.77e-04 | 152 | 93 | 5 | IPR001478 | |
| Domain | RA_dom | 1.03e-03 | 40 | 93 | 3 | IPR000159 | |
| Domain | TPR-like_helical_dom | 1.09e-03 | 233 | 93 | 6 | IPR011990 | |
| Domain | TPR_REGION | 1.41e-03 | 165 | 93 | 5 | PS50293 | |
| Domain | TPR | 1.41e-03 | 165 | 93 | 5 | PS50005 | |
| Domain | FERM_central | 1.87e-03 | 49 | 93 | 3 | IPR019748 | |
| Domain | FERM_domain | 1.87e-03 | 49 | 93 | 3 | IPR000299 | |
| Domain | FERM_1 | 1.98e-03 | 50 | 93 | 3 | PS00660 | |
| Domain | FERM_2 | 1.98e-03 | 50 | 93 | 3 | PS00661 | |
| Domain | FERM_3 | 1.98e-03 | 50 | 93 | 3 | PS50057 | |
| Domain | Band_41_domain | 1.98e-03 | 50 | 93 | 3 | IPR019749 | |
| Domain | B41 | 1.98e-03 | 50 | 93 | 3 | SM00295 | |
| Domain | TPR | 3.95e-03 | 129 | 93 | 4 | SM00028 | |
| Domain | TPR_repeat | 4.40e-03 | 133 | 93 | 4 | IPR019734 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 6.94e-05 | 18 | 64 | 3 | MM1549 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 1.48e-04 | 23 | 64 | 3 | M46455 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 2.01e-04 | 5 | 64 | 2 | M48999 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 2.42e-04 | 27 | 64 | 3 | M1718 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 3.00e-04 | 29 | 64 | 3 | M39762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 3.01e-04 | 6 | 64 | 2 | M47523 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.03e-04 | 32 | 64 | 3 | MM14975 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 7 | 64 | 2 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 4.20e-04 | 7 | 64 | 2 | M47790 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 5.58e-04 | 8 | 64 | 2 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 5.58e-04 | 8 | 64 | 2 | M47715 | |
| Pathway | WP_ACUTE_VIRAL_MYOCARDITIS | 5.94e-04 | 85 | 64 | 4 | M39776 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 7.16e-04 | 9 | 64 | 2 | M27732 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M22056 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 7.16e-04 | 9 | 64 | 2 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M47972 | |
| Pathway | REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1 | 7.16e-04 | 9 | 64 | 2 | MM15482 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 7.82e-04 | 40 | 64 | 3 | MM14945 | |
| Pathway | WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA | 7.82e-04 | 40 | 64 | 3 | M48337 | |
| Pathway | REACTOME_MTOR_SIGNALLING | 8.41e-04 | 41 | 64 | 3 | M27000 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 8.41e-04 | 41 | 64 | 3 | MM15200 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 8.92e-04 | 10 | 64 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 8.92e-04 | 10 | 64 | 2 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 8.92e-04 | 10 | 64 | 2 | M47615 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 8.92e-04 | 10 | 64 | 2 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 8.92e-04 | 10 | 64 | 2 | MM14778 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.03e-04 | 42 | 64 | 3 | MM15039 | |
| Pathway | REACTOME_MTOR_SIGNALLING | 9.03e-04 | 42 | 64 | 3 | MM14638 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 9.03e-04 | 42 | 64 | 3 | M27272 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.03e-04 | 42 | 64 | 3 | M7169 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 9.68e-04 | 43 | 64 | 3 | MM14609 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47406 | |
| Pathway | BIOCARTA_IL4_PATHWAY | 1.09e-03 | 11 | 64 | 2 | MM1413 | |
| Pathway | BIOCARTA_IL4_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M5415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 1.09e-03 | 11 | 64 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M47501 | |
| Pathway | SIG_CHEMOTAXIS | 1.11e-03 | 45 | 64 | 3 | M5193 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.25e-03 | 47 | 64 | 3 | MM14939 | |
| Pathway | PID_IL6_7_PATHWAY | 1.25e-03 | 47 | 64 | 3 | M183 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 12 | 64 | 2 | M47393 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 1.30e-03 | 12 | 64 | 2 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 1.30e-03 | 12 | 64 | 2 | MM15282 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 1.30e-03 | 12 | 64 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.30e-03 | 12 | 64 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.30e-03 | 12 | 64 | 2 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.30e-03 | 12 | 64 | 2 | M45022 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.30e-03 | 12 | 64 | 2 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.30e-03 | 12 | 64 | 2 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.30e-03 | 12 | 64 | 2 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.30e-03 | 12 | 64 | 2 | MM14550 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.42e-03 | 49 | 64 | 3 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.50e-03 | 50 | 64 | 3 | MM14610 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.53e-03 | 13 | 64 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 1.53e-03 | 13 | 64 | 2 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.53e-03 | 13 | 64 | 2 | M549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.59e-03 | 51 | 64 | 3 | MM15151 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 1.59e-03 | 51 | 64 | 3 | M7955 | |
| Pathway | WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM | 1.78e-03 | 14 | 64 | 2 | M48059 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.78e-03 | 14 | 64 | 2 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 1.78e-03 | 14 | 64 | 2 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 1.78e-03 | 14 | 64 | 2 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.78e-03 | 14 | 64 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.78e-03 | 14 | 64 | 2 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.78e-03 | 14 | 64 | 2 | M3862 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.95e-03 | 117 | 64 | 4 | MM15387 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.98e-03 | 55 | 64 | 3 | MM14917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 2.05e-03 | 15 | 64 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.05e-03 | 15 | 64 | 2 | M47663 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.05e-03 | 15 | 64 | 2 | M26902 | |
| Pathway | WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY | 2.05e-03 | 15 | 64 | 2 | M39431 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 2.05e-03 | 15 | 64 | 2 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 2.05e-03 | 15 | 64 | 2 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 2.05e-03 | 15 | 64 | 2 | M47971 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.30e-03 | 58 | 64 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.30e-03 | 58 | 64 | 3 | MM14736 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 2.34e-03 | 16 | 64 | 2 | M7721 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 2.64e-03 | 17 | 64 | 2 | M48086 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 2.64e-03 | 17 | 64 | 2 | M2482 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 2.64e-03 | 17 | 64 | 2 | MM1508 | |
| Pathway | SA_PTEN_PATHWAY | 2.64e-03 | 17 | 64 | 2 | M12771 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.67e-09 | 7 | 93 | 4 | 15710750 | |
| Pubmed | Differential regulation of Akt/protein kinase B isoforms during cell cycle progression. | 1.85e-08 | 3 | 93 | 3 | 19166849 | |
| Pubmed | An integrin axis induces IFN-β production in plasmacytoid dendritic cells. | 1.84e-07 | 5 | 93 | 3 | 35878016 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 3.68e-07 | 6 | 93 | 3 | 31996678 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 6.43e-07 | 7 | 93 | 3 | 11353387 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 30944974 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 6.43e-07 | 7 | 93 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 6.43e-07 | 7 | 93 | 3 | 17372272 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 38657106 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 21205196 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 18949001 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 25187515 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 8603673 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 26632511 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 24403063 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 23818861 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 23536549 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 12191015 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 22821000 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.03e-06 | 8 | 93 | 3 | 21670213 | |
| Pubmed | 1.03e-06 | 8 | 93 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.03e-06 | 8 | 93 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.03e-06 | 8 | 93 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.03e-06 | 8 | 93 | 3 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.54e-06 | 9 | 93 | 3 | 18394993 | |
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 28100513 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 17887960 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 11553612 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 10601307 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 9733766 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 28877029 | ||
| Pubmed | 2.19e-06 | 10 | 93 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.19e-06 | 10 | 93 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.19e-06 | 10 | 93 | 3 | 8857542 | |
| Pubmed | 2.19e-06 | 10 | 93 | 3 | 21859863 | ||
| Pubmed | 3.01e-06 | 11 | 93 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 3.01e-06 | 11 | 93 | 3 | 35771867 | |
| Pubmed | 3.01e-06 | 11 | 93 | 3 | 34110283 | ||
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 23275438 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.19e-06 | 13 | 93 | 3 | 31427429 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27878243 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27699769 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31348981 | ||
| Pubmed | Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. | 7.07e-06 | 2 | 93 | 2 | 31252679 | |
| Pubmed | Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. | 7.07e-06 | 2 | 93 | 2 | 19622728 | |
| Pubmed | Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients. | 7.07e-06 | 2 | 93 | 2 | 28271235 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17019809 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33377281 | ||
| Pubmed | Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. | 7.07e-06 | 2 | 93 | 2 | 9620559 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 11861503 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12808085 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15010337 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 36229454 | ||
| Pubmed | Akt2 regulates cardiac metabolism and cardiomyocyte survival. | 7.07e-06 | 2 | 93 | 2 | 16950770 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20332370 | ||
| Pubmed | AKT has an anti-apoptotic role in ABCA12-deficient keratinocytes. | 7.07e-06 | 2 | 93 | 2 | 21633372 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 3037531 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 32078465 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23076793 | ||
| Pubmed | Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. | 7.07e-06 | 2 | 93 | 2 | 19110052 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23919516 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17804734 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27408773 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17141631 | ||
| Pubmed | PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement. | 7.07e-06 | 2 | 93 | 2 | 31781306 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12620806 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30692211 | ||
| Pubmed | Distinct actions of akt1 on skeletal architecture and function. | 7.07e-06 | 2 | 93 | 2 | 24663486 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19491266 | ||
| Pubmed | Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. | 7.07e-06 | 2 | 93 | 2 | 17609365 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17825284 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31847370 | ||
| Pubmed | Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. | 7.07e-06 | 2 | 93 | 2 | 26654940 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 16923802 | ||
| Pubmed | Role of AMPK and Akt in triple negative breast cancer lung colonization. | 7.07e-06 | 2 | 93 | 2 | 33839456 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21432781 | ||
| Pubmed | Molecular alterations in AKT and its protein activation in human lung carcinomas. | 7.07e-06 | 2 | 93 | 2 | 22748472 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 17045205 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31671832 | ||
| Pubmed | PKB signaling and atrogene expression in skeletal muscle of aged mice. | 7.07e-06 | 2 | 93 | 2 | 21551011 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 24769357 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23567263 | ||
| Pubmed | Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. | 7.07e-06 | 2 | 93 | 2 | 16365168 | |
| Pubmed | Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. | 7.07e-06 | 2 | 93 | 2 | 15102693 | |
| Pubmed | AKT1 and AKT2 induce distinct phosphorylation patterns in HL-1 cardiac myocytes. | 7.07e-06 | 2 | 93 | 2 | 25162660 | |
| Pubmed | The Akt1 isoform is an essential mediator of ischaemic preconditioning. | 7.07e-06 | 2 | 93 | 2 | 22117619 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21532616 | ||
| Pubmed | Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. | 7.07e-06 | 2 | 93 | 2 | 19142853 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15545269 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 22275470 | ||
| Pubmed | Specific and redundant roles of PKBα/AKT1 and PKBβ/AKT2 in human pancreatic islets. | 7.07e-06 | 2 | 93 | 2 | 26318486 | |
| Pubmed | Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. | 7.07e-06 | 2 | 93 | 2 | 25136137 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 22480544 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33565714 | ||
| Pubmed | Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. | 7.07e-06 | 2 | 93 | 2 | 22647600 | |
| Pubmed | Akt isoform-specific inhibition of MDA-MB-231 cell proliferation. | 7.07e-06 | 2 | 93 | 2 | 20688159 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26971877 | ||
| Interaction | RGPD4 interactions | 2.79e-06 | 22 | 92 | 4 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 6.59e-06 | 27 | 92 | 4 | int:RGPD2 | |
| GeneFamily | PDZ domain containing | 2.16e-04 | 152 | 65 | 5 | 1220 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.70e-04 | 50 | 65 | 3 | 1293 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.80e-04 | 115 | 65 | 4 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.68e-04 | 206 | 65 | 5 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 1.77e-03 | 242 | 65 | 5 | 403 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 5.62e-06 | 33 | 93 | 4 | MM477 | |
| Coexpression | GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 4.08e-05 | 177 | 93 | 6 | M6703 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_DN | 7.82e-05 | 199 | 93 | 6 | M5439 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 7.82e-05 | 199 | 93 | 6 | M6001 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | 7.82e-05 | 199 | 93 | 6 | M4331 | |
| Coexpression | GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP | 8.04e-05 | 200 | 93 | 6 | M6369 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 8.04e-05 | 200 | 93 | 6 | M6447 | |
| Coexpression | GSE13229_IMM_VS_MATURE_NKCELL_UP | 8.04e-05 | 200 | 93 | 6 | M3205 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_UP | 8.04e-05 | 200 | 93 | 6 | M3811 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 9.12e-05 | 127 | 93 | 5 | M40905 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cadm2_(Cadm2+_state)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.14e-06 | 59 | 93 | 4 | b2c10c4c0a750d7f49f5a813ab5d103fb07ca76b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cadm2_(Cadm2+_state)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.14e-06 | 59 | 93 | 4 | bcac768e1e034e27bab7cad3c2bf09a8f0a819ad | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cadm2_(Cadm2+_state)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.14e-06 | 59 | 93 | 4 | f9b9464f4d786991aad01b47e2a8fd33f889c2e2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.43e-05 | 147 | 93 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 1.85e-05 | 155 | 93 | 5 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 158 | 93 | 5 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.97e-05 | 171 | 93 | 5 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.97e-05 | 171 | 93 | 5 | 341f9f79c1ed654ab347e25dc4936f89ffdf9617 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.97e-05 | 171 | 93 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-05 | 177 | 93 | 5 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.59e-05 | 178 | 93 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.21e-05 | 184 | 93 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 184 | 93 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.21e-05 | 184 | 93 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.21e-05 | 184 | 93 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 185 | 93 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 185 | 93 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 188 | 93 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 188 | 93 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 188 | 93 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-05 | 189 | 93 | 5 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.41e-05 | 194 | 93 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.54e-05 | 195 | 93 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 197 | 93 | 5 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 197 | 93 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 197 | 93 | 5 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.82e-05 | 197 | 93 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.82e-05 | 197 | 93 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.82e-05 | 197 | 93 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 198 | 93 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.96e-05 | 198 | 93 | 5 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 198 | 93 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.10e-05 | 199 | 93 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 199 | 93 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.25e-05 | 200 | 93 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.91e-04 | 7 | 90 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | microcephaly (is_implicated_in) | 2.55e-04 | 8 | 90 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.57e-04 | 49 | 90 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 4.61e-04 | 117 | 90 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | Gastrointestinal Diseases | 5.95e-04 | 12 | 90 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 5.95e-04 | 12 | 90 | 2 | C0559031 | |
| Disease | Cholera Infantum | 5.95e-04 | 12 | 90 | 2 | C1565321 | |
| Disease | Mental Retardation, Psychosocial | 8.81e-04 | 139 | 90 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 8.81e-04 | 139 | 90 | 4 | C0020796 | |
| Disease | Mental deficiency | 8.81e-04 | 139 | 90 | 4 | C0917816 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 9.41e-04 | 15 | 90 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | impotence (implicated_via_orthology) | 9.41e-04 | 15 | 90 | 2 | DOID:1875 (implicated_via_orthology) | |
| Disease | inherited metabolic disorder (is_implicated_in) | 9.41e-04 | 15 | 90 | 2 | DOID:655 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 1.14e-03 | 525 | 90 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.14e-03 | 525 | 90 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 1.16e-03 | 527 | 90 | 7 | C1458155 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.24e-03 | 69 | 90 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 1.31e-03 | 538 | 90 | 7 | C0678222 | |
| Disease | Lung Neoplasms | 1.33e-03 | 265 | 90 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.35e-03 | 266 | 90 | 5 | C0242379 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.38e-03 | 157 | 90 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.40e-03 | 268 | 90 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 1.41e-03 | 72 | 90 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 1.52e-03 | 19 | 90 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Pancreatic carcinoma | 1.52e-03 | 19 | 90 | 2 | C0235974 | |
| Disease | Amphetamine-Related Disorders | 1.58e-03 | 75 | 90 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 1.58e-03 | 75 | 90 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 1.58e-03 | 75 | 90 | 3 | C0236804 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.69e-03 | 20 | 90 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | left atrial function | 1.86e-03 | 21 | 90 | 2 | EFO_0004294 | |
| Disease | systemising measurement | 1.86e-03 | 21 | 90 | 2 | EFO_0010221 | |
| Disease | BREAST CANCER | 1.86e-03 | 21 | 90 | 2 | 114480 | |
| Disease | Nasopharyngeal carcinoma | 2.04e-03 | 22 | 90 | 2 | C2931822 | |
| Disease | malignant astrocytoma (is_marker_for) | 2.23e-03 | 23 | 90 | 2 | DOID:3069 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_marker_for) | 2.26e-03 | 85 | 90 | 3 | DOID:3910 (is_marker_for) | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 90 | 6 | C3714756 | |
| Disease | diet measurement, bilirubin measurement | 2.85e-03 | 26 | 90 | 2 | EFO_0004570, EFO_0008111 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.04e-03 | 195 | 90 | 4 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVKEGWLHKRGEYIK | 6 | P31749 | |
| VIKEGWLHKRGEYIK | 6 | P31751 | |
| VHYNGVLAAKLWRKK | 516 | P16452 | |
| IHKADWIRKYNPDTL | 1546 | Q9HCK8 | |
| EWAIIKAPGYKHDIK | 206 | P32297 | |
| WLRKGYIKHKPDQMT | 211 | Q96BT7 | |
| LYGSIKVPHWTKKQL | 1441 | Q86UK0 | |
| VVVHKKKRPVLRDYW | 431 | P27037 | |
| KKRPVLRDYWQKHAG | 436 | P27037 | |
| YWKLQKKEHPPEVSR | 6 | Q9NWN3 | |
| EVKPKILANGARWKY | 31 | Q96IZ2 | |
| VGWRHYDVAKKLKEL | 171 | Q8TF65 | |
| FWLPLLEKVYAKVHG | 146 | Q9HC96 | |
| QHEYDIWPPAGKERK | 1536 | Q8WZ64 | |
| KIKENKHPFALYGWG | 176 | Q6IQ19 | |
| SEEKKYRPAEFHWKL | 436 | O94985 | |
| YKKRLEDLGVPVTWH | 356 | Q5VUY0 | |
| GHLQIPKWRYKEAKE | 451 | A6NCL7 | |
| GKKPHYREIVWVKVG | 1751 | Q96L73 | |
| LKHQILPKEQWTKYE | 71 | P14927 | |
| GRSVHYWKKVLPLLK | 601 | Q99666 | |
| GRSVHYWKKVLPLLK | 601 | O14715 | |
| VWRHSPKKQKNGYEK | 126 | P23458 | |
| TWKYLLHEKLNLPVE | 66 | Q9NWS1 | |
| HLLKQIKVKGPRYWE | 1661 | Q9H1A4 | |
| KHYREWAGALVKDGK | 511 | Q8TDY2 | |
| KTREKGPGYWVKIHH | 36 | Q8TEW8 | |
| LKERKEEKCHQYWPD | 236 | P23469 | |
| KWYRILKQEHPELAV | 311 | Q6NYC1 | |
| LKKVQPWHAGQYEIL | 781 | Q15746 | |
| WKGKDLLRIPHELYQ | 216 | Q9HBL6 | |
| EKAVIWPQYVKDRIH | 111 | Q9H3K2 | |
| QYHWEELKGPLREEK | 441 | Q8IZA0 | |
| KLWNYAKTPHRGVKE | 1501 | O60303 | |
| GVIYKIKLRHDNSKW | 1316 | Q8IVV2 | |
| LKRNPGNHLYKWKQI | 266 | P17181 | |
| TKVWNQIKPYIRHKD | 561 | Q6AI08 | |
| VRKFQPERYKLWKAG | 321 | O75164 | |
| IERKLNVYHKGAKIW | 391 | Q6X4W1 | |
| DVKGTYEPGKRHWLK | 661 | P49916 | |
| RHWLKVKKDYLNEGA | 671 | P49916 | |
| YKWIKDNISPKLHVD | 751 | P78344 | |
| KIYKHAGNIKEAARW | 416 | Q9BXJ9 | |
| FGIKRPEHKKLYSWQ | 341 | Q8IVE3 | |
| IRHPKFEWFKDLGLK | 551 | P29475 | |
| GRSVHYWKKVLPLLK | 601 | A6NKT7 | |
| WVVSKRGKDYILKHI | 186 | Q96NE9 | |
| KAQAKYKEWLPHLLV | 386 | Q9Y575 | |
| RKDLEKWLKEHPGYV | 2506 | Q3L8U1 | |
| DQAKYLNPLLGEWKH | 316 | Q53GT1 | |
| LRYKKLHDPKGWITI | 506 | Q14574 | |
| KKKGGNHIPERWKDY | 71 | O75319 | |
| WAEYDPEAKGRIKHL | 1406 | Q13698 | |
| ILLDIKQRHKPWYEE | 581 | Q96PZ2 | |
| LANWGLPKAVLEKYH | 71 | O75417 | |
| RTHKPDWNYIIKFVK | 2471 | A8TX70 | |
| EKRLSLEQIQKHPWY | 271 | Q8TDC3 | |
| AKLWGEEYNRHKPPK | 191 | O00418 | |
| RWHVARKPLDVYKKP | 451 | Q13822 | |
| KAIAKDPNYWIQVHR | 36 | Q8TEW0 | |
| ELYWDLEKKAKRQGP | 26 | Q8TC84 | |
| KKPLHVNFKELGWDD | 356 | Q6KF10 | |
| DKEGNKLFWIRVKYH | 101 | Q8NHP6 | |
| KGIHKNTWELKPEYR | 226 | P13984 | |
| GRSVHYWKKVLPLLK | 601 | Q7Z3J3 | |
| RGTWEKLPSKYEKHL | 966 | Q8TEU7 | |
| KQWKDLQGEAPYHLL | 1006 | Q8NF91 | |
| DMPWLALPYKEKHRK | 106 | Q6DKJ4 | |
| YPKAIFQKHRIEQWK | 2651 | Q96Q15 | |
| WPFPKDLNGKAVKYH | 301 | Q92187 | |
| ALKEKEEPHYIEIWK | 811 | Q96T21 | |
| QLDSVRVWLGKHYKK | 51 | Q92922 | |
| QKIKEKHREEFPGWV | 391 | O94993 | |
| QKRLKQGLYRHPWDD | 1076 | P53396 | |
| HRPEKEWPIKSLKVY | 1331 | Q96P48 | |
| AKLLDKHYPGKQAWE | 56 | Q7RTR0 | |
| KKYKLWGLHIPSDQE | 141 | Q9BXU1 | |
| ALEPWKHYVPIKRNL | 406 | Q7Z4H8 | |
| VKRYLWQHLKKHVVP | 586 | Q63HN8 | |
| WHRKKQAGIPKEEEY | 21 | Q9Y5R8 | |
| KLRVHKARQWKYDGE | 636 | Q99973 | |
| TEKILYRLDVGWPKH | 41 | Q5JS37 | |
| GSHWKQKRKFLPEDI | 236 | P10828 | |
| EQLLYEHWKKNNPKL | 136 | Q9BT92 | |
| IKGKRHWYEALPQAV | 881 | O15040 | |
| KELILDKVYTHPKWN | 61 | Q53FD0 | |
| RGEWKKLEPFQKELY | 181 | Q8TF39 | |
| ELDNPHKQKAWKIYP | 496 | Q6XPS3 | |
| YKPPGLKWKHLRDTV | 16 | O95900 | |
| PKGQKYECAKRWNVH | 246 | Q92547 | |
| HLYKWAIPAEGKKNE | 201 | Q9HC21 | |
| KRIHTGEQPYKWEKF | 621 | O75437 | |
| PETNIKGKLAYWKHN | 276 | A6PVS8 | |
| RGWLQKVKYHRLKGA | 776 | Q9ULV0 | |
| QKHKYKVLFREPDTW | 531 | Q86UW6 |